How to Help Your Patients Find Midazolam in Stock: A Provider's Guide

When a patient calls your office unable to fill their midazolam prescription, the challenge is compounded by the medication's Schedule IV status, its specialty-pharmacy dependence for certain formulations, and its clinical urgency — particularly for epilepsy patients who rely on Nayzilam as their seizure rescue medication. This guide provides actionable steps your practice can take to help patients efficiently locate midazolam and, when necessary, transition to an evidence-based alternative.

Understanding the Root Cause: Why Patients Can't Fill Midazolam

Patients typically face one of these scenarios when they can't fill a midazolam prescription:

Nayzilam not in stock at local chain pharmacies: Nayzilam is a specialty product not regularly stocked at Walgreens, CVS, or Rite Aid branches. Patients may not know specialty pharmacies are an option.

Midazolam oral syrup unavailable: The 2 mg/mL oral syrup is niche and not stocked at all retail locations; compounding pharmacies may be needed.

Injectable concentration mismatch: The specific injectable concentration (1 mg/mL vs. 5 mg/mL) or vial size is unavailable at the dispensing pharmacy.

Wholesale backorder: A regional distributor or wholesaler is backordered on a particular midazolam product, affecting multiple pharmacies simultaneously.

Step 1: Use medfinder to Find Pharmacy Availability

The most efficient first step is to direct patients to medfinder for Providers. medfinder calls pharmacies within the patient's area to identify which ones can fill the specific midazolam prescription. Patients receive results by text message, avoiding hours of phone calls. This is particularly valuable for time-sensitive situations like seizure rescue medications.

Consider keeping medfinder.com/providers in your patient handout materials and after-visit summaries for any patient prescribed a midazolam formulation.

Step 2: Specify the NDC on the Prescription

Specifying the National Drug Code (NDC) on the prescription helps pharmacies source the exact product. This is particularly important for Nayzilam, where UCB's specific product code distinguishes it from compounded midazolam nasal preparations. For injectable midazolam, specifying the preferred manufacturer (e.g., Hikma, Fresenius Kabi, Pfizer) and concentration can also help pharmacists locate the right product.

Step 3: Direct Nayzilam Patients to UCB Patient Support

UCB, the manufacturer of Nayzilam, operates a robust patient support program. Your patients can:

Call UCB patient support at 1-888-786-5879 to be connected with a specialty pharmacy that stocks Nayzilam

Enroll in the Nayzilam Patient Savings Card program to reduce out-of-pocket costs

Access patient assistance if they meet income eligibility criteria

Your office's medical assistant or care coordinator can make this call on behalf of a patient and arrange pharmacy transfer in minutes.

Step 4: Know When to Prescribe an Alternative

For epilepsy patients who cannot obtain Nayzilam in a clinically acceptable time frame, having an alternative rescue prescription ready is critical patient safety practice. Discuss and document a backup plan at every visit for patients on Nayzilam:

Valtoco (diazepam nasal spray): FDA-approved for ages 2+; available in 5 mg, 7.5 mg, 10 mg doses; manufactured by Neurelis

Diastat (rectal diazepam): Widely available, long track record, approved for ages 2+; less preferred by families but effective

Step 5: Consider Compounding for Oral Syrup

When the commercial midazolam oral syrup (2 mg/mL) is unavailable for pediatric procedural sedation, PCAB-accredited compounding pharmacies can prepare the formulation. Verify that the compounding pharmacy uses USP standards and that the prescription specifies the required concentration, quantity, and flavoring if applicable.

Patient Communication Scripts

When a patient reports they can't fill their midazolam prescription, your staff can use this script:

"We're sorry you're having trouble finding this medication. We recommend trying medfinder.com, which calls pharmacies near you to find out who has it in stock — you'll get results by text message. For Nayzilam specifically, you can also call UCB's support line at 1-888-786-5879. We have also noted an alternative rescue prescription in your record that your provider can send if needed. Please call us back if you are still unable to fill within 24 hours."

Documentation Best Practices

Document the backup rescue prescription plan in the chart (for epilepsy patients)

Note specific NDC preferences for patients with formulation-specific needs

Track which pharmacies in your area reliably stock Nayzilam and keep the list updated in your practice management system

For the broader clinical picture on midazolam availability and alternatives, see: Midazolam Shortage: What Providers and Prescribers Need to Know in 2026.